Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry

被引:603
作者
Farzan, M
Mirzabekov, T
Kolchinsky, P
Wyatt, R
Cayabyab, M
Gerard, NP
Gerard, C
Sodroski, J
Choe, H
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol,Div Human Retrovirol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Canc Biol, Boston, MA 02115 USA
[3] Childrens Hosp, Ina Sue Perlmutter Lab, Boston, MA 02115 USA
[4] Beth Israel Hosp, Dept Med, Boston, MA 02115 USA
[5] Beth Israel Hosp, Dept Pediat, Boston, MA 02115 USA
关键词
D O I
10.1016/S0092-8674(00)80577-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemokine receptors and related seven-transmembrane-segment (7TMS) receptors serve as coreceptors for entry of human and simian immunodeficiency viruses (HIV-1, HIV-2, and SIV) into target cells. Each of these otherwise diverse coreceptors contains an N-terminal region that is acidic and tyrosine rich. Here, we show that the chemokine receptor CCR5, a principal HIV-1 coreceptor, is posttranslationally modified by O-linked glycosylation and by sulfation of its N-terminal tyrosines. Sulfated tyrosines contribute to the binding of CCR5 to MIP-1 alpha, MIP-1 beta, and HIV-1 gp120/CD4 complexes and to the ability of HIV-1 to enter cells expressing CCR5 and CD4. CXCR4, another important HIV-1 coreceptor, is also sulfated. Tyrosine sulfation may contribute to the natural function of many 7TMS receptors and may be a modification common to primate immunodeficiency virus coreceptors.
引用
收藏
页码:667 / 676
页数:10
相关论文
共 56 条
[31]  
MINTZ KP, 1994, J BIOL CHEM, V269, P4845
[32]   Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans [J].
Mondor, I ;
Ugolini, S ;
Sattentau, QJ .
JOURNAL OF VIROLOGY, 1998, 72 (05) :3623-3634
[33]   The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1 alpha receptor, confers chemokine selectivity - Evidence for a two-step mechanism for MCP-1 receptor activation [J].
Monteclaro, FS ;
Charo, IF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19084-19092
[34]  
Oravecz T, 1997, J IMMUNOL, V159, P4587
[35]   Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry [J].
Pleskoff, O ;
Treboute, C ;
Brelot, A ;
Heveker, N ;
Seman, M ;
Alizon, M .
SCIENCE, 1997, 276 (5320) :1874-1878
[36]   PSGL-1 RECOGNITION OF P-SELECTIN IS CONTROLLED BY A TYROSINE SULFATION CONSENSUS AT THE PSGL-1 AMINO-TERMINUS [J].
POUYANI, T ;
SEED, B .
CELL, 1995, 83 (02) :333-343
[37]   Chemokine receptors: Gateways to inflammation and infection [J].
Premack, BA ;
Schall, TJ .
NATURE MEDICINE, 1996, 2 (11) :1174-1178
[38]   Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1 [J].
Rabut, GEE ;
Konner, JA ;
Kajumo, F ;
Moore, JP ;
Dragic, T .
JOURNAL OF VIROLOGY, 1998, 72 (04) :3464-3468
[39]   Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1 beta, and MIP-1 alpha [J].
Raport, CJ ;
Gosling, J ;
Schweickart, VL ;
Gray, PW ;
Charo, IF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (29) :17161-17166
[40]   A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding [J].
Rizzuto, CD ;
Wyatt, R ;
Hernández-Ramos, N ;
Sun, Y ;
Kwong, PD ;
Hendrickson, WA ;
Sodroski, J .
SCIENCE, 1998, 280 (5371) :1949-1953